nad has been researched along with Hamartoma Syndrome, Multiple in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Eng, C; He, X; Mester, J; Moline, J; Ni, Y; Orloff, MS; Ringel, MD | 1 |
1 other study(ies) available for nad and Hamartoma Syndrome, Multiple
Article | Year |
---|---|
Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Topics: Breast Neoplasms; Female; Flavin-Adenine Dinucleotide; Genes, p53; Genetic Carrier Screening; Genetic Predisposition to Disease; Germ-Line Mutation; Hamartoma Syndrome, Multiple; Humans; NAD; PTEN Phosphohydrolase; Succinate Dehydrogenase; Thyroid Neoplasms | 2012 |